In this interview, Dr. Nathan Goodyear discusses the benefits of vitamin C in cancer treatment. We are both scheduled speakers at the Vitamin C International Consortium Institute’s annual conference in Tampa, Florida, September 9 and 10, 2022. Goodyear started out as a gynecologist and pelvic floor surgeon. Once out of residency, however, he noticed that… Read More »
Oonagh McArdle had always been a healthy, fit, non-smoker so when she began experiencing “strange” symptoms in 2019, she was only mildly concerned, but decided to visit her doctor just in case. Several months and tests later, she received the biggest shock of her life when it was discovered that the strange feeling in her… Read More »
A skin pigmentation mechanism that can darken the color of human skin as a natural defense against ultraviolet (UV)-associated cancers has been discovered by scientists at Harvard-affiliated Massachusetts General Hospital (MGH). Mediating the biological process is an enzyme called nicotinamide nucleotide transhydrogenase (NNT), which plays a key role in the production of melanin (a pigment… Read More »
Shoddy, incomplete, fawning news coverage of screening tests is one of the most clearly established problems in health news coverage – something HealthNewsReview.org has revealed countless times over the past 15 years. A public relations news release 22 days ago – from “a healthcare company whose mission is to detect cancer early” – touted study… Read More »
According to researchers at Marshall University, a maternal diet rich in Omega-3 fatty acids protects from breast cancer development in offspring. In a new study recently published by Frontiers in Cell and Developmental Biology, researchers noted a significant difference in mice from mothers that were fed a diet rich in canola oil, compared with mothers… Read More »
FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of Rybrevant (amivantamab-vmjw) for the… Read More »